Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Dow
Mallinckrodt
Moodys
Medtronic

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PROPYLTHIOURACIL

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Propylthiouracil

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00677469 Low Doses of Cholestyramine in the Treatment of Hyperthyroidism Completed Shiraz University of Medical Sciences N/A 2007-07-01 The enterohepatic circulation of thyroid hormones is increased in thyrotoxicosis.Bile-salt sequestrants (ionic exchange resins) bind thyroid hormones in the intestine and thereby increase their fecal excretion. Based on these observations, the use of cholestyramine has been tried. The present study evaluates the effect of low doses of cholestyramine as an adjunctive therapy in the management of hyperthyroidism
NCT00946296 Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease Completed University of Massachusetts, Worcester Phase 4 2005-04-01 The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.
NCT01436994 Antithyroid Drug Treatment of Thyrotoxicosis in Young People Completed Newcastle-upon-Tyne Hospitals NHS Trust Phase 3 2004-07-01 The investigators aim to establish whether biochemical control during anti-thyroid drug therapy in young people with thyrotoxicosis varies depending upon whether a 'block and replace' or 'dose titration' regimen is used. The investigators will also assess remission rates and the frequency of side-effects in the two treatment groups.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Propylthiouracil

Condition Name

Condition Name for Propylthiouracil
Intervention Trials
Graves Disease 4
Hyperthyroidism 2
GravesĀ“ Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Propylthiouracil
Intervention Trials
Graves Disease 5
Hyperthyroidism 3
Neoplasm Metastasis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Propylthiouracil

Trials by Country

Trials by Country for Propylthiouracil
Location Trials
Malaysia 3
United Kingdom 1
United States 1
China 1
Iran, Islamic Republic of 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Propylthiouracil
Location Trials
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Propylthiouracil

Clinical Trial Phase

Clinical Trial Phase for Propylthiouracil
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Propylthiouracil
Clinical Trial Phase Trials
Completed 5
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Propylthiouracil

Sponsor Name

Sponsor Name for Propylthiouracil
Sponsor Trials
Dr Cipto Mangunkusumo General Hospital 1
Indonesia University 1
Mikael Lantz 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Propylthiouracil
Sponsor Trials
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
AstraZeneca
Johnson and Johnson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.